<DOC>
	<DOCNO>NCT00484575</DOCNO>
	<brief_summary>Inhaled sevoflurane coronary artery bypass grafting ( CABG ) reduce postoperative Troponin level may associate improved outcome . A dose-response effect demonstrate de Hert et al , great reduction Troponin Sevoflurane use entire operation , compare Sevoflurane part operation . Sevoflurane , inhale anesthetic agent , sedative low dos . Postoperative sedation CABG currently achieve intravenous propofol . A new simplify method administration isoflurane sevoflurane develop tested member research group . The Anesthetic Conserving Device modify heat-moisture exchanger ( HME ) permit direct infusion sevoflurane airway , vaporize evaporator rod device . The primary aim ( primary hypothesis ) current trial examine postoperative sedation sevoflurane CABG associate improved cardiac outcome , measure reduced level Troponin , BNP reduce incidence cardiac event , atrial fibrillation , need inotropic drug myocardial infarction , compare conventional propofol sedation . Other end-points trial potential renal ( protective ) effect measure cystatin C level , need dialysis also measurements inorganic fluoride serum , well environmental aspect sevoflurane sedation Cardiothoracic Intensive Care Unit . Furthermore , potential difference ICU memories well-being stay intensive Care Unit investigate via patient questionnaire . Besides routine blood sampling , plasma save later analysis inflammatory mediator ( biobank ) .</brief_summary>
	<brief_title>Inhaled Sevoflurane Compared Intravenous Sedation Post Coronary Artery Bypass Grafting</brief_title>
	<detailed_description>Sevoflurane , inhale anesthetic currently recommend anesthesia coronary artery bypass grafting ( CABG ) . Inhaled sevoflurane CABG reduce postoperative Troponin level may associate improved outcome . A dose-response effect Sevoflurane cardioprotection demonstrate de Hert et al , great reduction Troponin Sevoflurane use entire operation , compare Sevoflurane part operation . Postoperative sedation CABG currently achieve intravenous propofol . Sevoflurane , inhale anesthetic agent , sedative low dos . A new simplify method administration isoflurane sevoflurane develop tested member research group . The Anesthetic Conserving Device ( AnaConDa® ) modify heat-moisture exchanger ( HME ) permit direct infusion sevoflurane airway , vaporize evaporator rod device . Studies isoflurane sedation AnaConDa® show good sedation effect short wake-up time . The primary aim ( primary hypothesis ) current trial examine postoperative sedation sevoflurane CABG associate improved cardiac outcome , measure reduced level Troponin , BNP reduce incidence cardiac event , atrial fibrillation , need inotropic drug myocardial infarction , compare conventional propofol sedation . Other end-points trial potential renal ( protective ) effect measure cystatin C level , need dialysis also measurements inorganic fluoride serum , well environmental aspect sevoflurane sedation Cardiothoracic Intensive Care Unit . Furthermore , potential difference ICU memories well-being stay intensive Care Unit investigate via patient questionnaire . Besides routine blood sampling , plasma save later analysis inflammatory mediator ( biobank ) . Methods : 120 patient plan CABG ( without valve surgery ) enrol trial . Patients malignant hyperthermia exclude , well patient need mechanical circulation support . Routine anesthesia CABG follow randomisation either inhale sevoflurane intravenous propofol . Patients transfer operating room Cardiothoracic Intensive Care Unit ( CICU ) propofol sedation . Upon arrival CICU sedation accord randomisation replace propofol . Thereafter patient keep sedated accord MAAS Scale vital parameter stable extubation criterion fulfil maximum 48 hour . Time arrival CICU extubation , well time termination sedative extubation measure . Total time CICU record well time arrival discharge criterion fulfil . Troponin , BNP , Creatinine , Cystatin C , CRP measure CABG , regular time interval postoperatively . A blood sample storage plasma take 12 hour postoperatively , preliminary measurement interleukin activity may attenuate inhaled anesthetic . Hemodynamics record CICU care , well need inotropic drug , cardioversion , arrythmias adverse event . Environment monitor dosimeter measurement spectrophotometry . After extubation patient monitor regard cognitive recovery first hour . When discharged CICU , patient receive questionnaire order describe memory panorama ICU stay 1-2 day .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Myocardial Reperfusion Injury</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Planned coronary artery bypass grafting Combined heart valve surgery Malignant Hyperthermia Postoperative need mechanical circulation support</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Sevoflurane</keyword>
	<keyword>CABG</keyword>
	<keyword>cardioprotection</keyword>
	<keyword>AnaConDa</keyword>
</DOC>